Chromogranin A promoter (CgA promoter)

The Chromogranin A (CgA) promoter is a DNA regulatory sequence responsible for the tissue-specific expression of the CHGA gene in neuroendocrine cells (UniProt P10645). In the context of oncology, this promoter is highly active in neuroendocrine tumor (NET) cells, including carcinoid tumors, pheochromocytomas, and small cell lung cancer (PubMed 11033162). This high specificity makes the CgA promoter a valuable tool for transcriptional targeting in gene therapy and oncolytic virotherapy (PubMed 15150596). By placing therapeutic genes or viral replication genes, such as E1A, under the control of the CgA promoter, researchers can ensure that the treatment is selectively activated within neuroendocrine malignant cells while sparing non-neuroendocrine tissues (Cancer Research 2004;64:3633-41). While the promoter itself is not a target for traditional small molecule inhibition, it serves as a critical targeting moiety for advanced biological therapeutics like the oncolytic adenovirus CG7870. Clinical monitoring of these therapies often involves measuring the CgA protein in the blood, which serves as a surrogate biomarker for promoter activity and tumor burden (PubMed 12062403). Safety considerations include the potential for off-target effects in healthy neuroendocrine tissues, such as the adrenal medulla and the pituitary gland, where the promoter is also naturally active.

Other names

CHGA promoterChromogranin A gene promoter regionCgA regulatory element

Transcriptional targeting for selective gene expression or viral replication in neuroendocrine cells.